Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Last Close
May 05  •  04:00PM ET
157.04
Dollar change
+2.96
Percentage change
1.92
%
May 05, 7:37 PMDaVita beats Q1 2026 estimates with EPS $2.87, revenue $3.416B and raises 2026 earnings outlook on better volume, labor productivity
Index
S&P 500
P/E
16.44
EPS (ttm)
9.55
Insider Own
2.28%
Shs Outstand
68.55M
Perf Week
4.64%
Market Cap
10.36B
Forward P/E
9.37
EPS next Y
16.76
Insider Trans
-65.69%
Shs Float
64.44M
Perf Month
4.61%
Enterprise Value
24.46B
PEG
0.48
EPS next Q
3.71
Inst Own
98.51%
Perf Quarter
16.56%
Income
721.80M
P/S
0.76
EPS this Y
34.23%
Inst Trans
-1.14%
Perf Half Y
31.94%
Sales
13.64B
P/B
-
EPS next Y
15.79%
ROA
4.00%
Perf YTD
38.23%
Book/sh
-9.50
P/C
13.24
EPS next 5Y
19.58%
ROE
635.30%
52W High
159.42 -1.49%
Perf Year
10.93%
Cash/sh
11.86
P/FCF
7.89
EPS past 3/5Y
18.56% 8.29%
ROIC
6.18%
52W Low
101.00 55.49%
Perf 3Y
77.51%
EV/EBITDA
8.97
Sales past 3/5Y
5.53% 3.39%
Gross Margin
27.00%
Volatility
3.94% 2.67%
Perf 5Y
28.17%
EV/Sales
1.79
EPS Y/Y TTM
-11.49%
Oper. Margin
14.74%
ATR (14)
4.46
Perf 10Y
107.09%
Quick Ratio
1.24
Sales Y/Y TTM
6.46%
Profit Margin
5.29%
RSI (14)
59.80
Current Ratio
1.29
EPS Q/Q
-5.07%
SMA20
4.02%
Beta
0.84
Debt/Eq
-
Sales Q/Q
9.87%
SMA50
3.69%
Rel Volume
2.29
Prev Close
154.08
Employees
78000
LT Debt/Eq
-
SMA200
18.06%
Avg Volume
863.16K
Price
157.04
IPO
Oct 31, 1995
Option/Short
Yes / Yes
Trades
Volume
1,997,962
Change
1.92%
Date Action Analyst Rating Change Price Target Change
Mar-06-24Initiated Barclays Equal Weight $133
Aug-07-23Upgrade UBS Neutral → Buy $100 → $142
Nov-01-22Downgrade Deutsche Bank Buy → Hold $97 → $72
Oct-31-22Downgrade UBS Buy → Neutral $117 → $74
Aug-19-22Resumed UBS Buy $106 → $117
Jun-21-22Reiterated BofA Securities Underperform $110 → $90
Sep-10-21Initiated Cowen Market Perform $145
Aug-12-21Downgrade Barclays Overweight → Equal Weight $135 → $146
Mar-26-21Downgrade BofA Securities Neutral → Underperform $127 → $118
Jan-05-21Downgrade BofA Securities Buy → Neutral $127
May-05-26 04:05PM
Apr-20-26 02:06PM
Mar-31-26 08:06PM
Mar-18-26 03:00PM
Mar-06-26 11:49AM
12:40PM Loading…
Mar-05-26 12:40PM
Mar-04-26 11:30AM
10:08AM
Mar-03-26 06:56PM
Feb-27-26 04:48AM
04:03AM
03:50AM
Feb-24-26 02:00PM
09:40AM
02:53AM
09:40AM Loading…
Feb-23-26 09:40AM
Feb-20-26 09:50AM
04:09AM
Feb-19-26 09:20AM
05:30AM
04:34AM
Feb-17-26 04:53PM
Feb-13-26 10:24AM
Feb-12-26 11:03AM
10:54AM
10:41AM
09:25AM
Feb-11-26 09:15AM
Feb-10-26 12:30PM
09:32AM
10:38AM Loading…
Feb-09-26 10:38AM
08:50AM
12:31AM
Feb-05-26 09:40AM
09:40AM
Feb-04-26 07:55PM
02:54PM
10:59AM
Feb-03-26 06:03PM
04:26PM
01:18PM
12:38PM
12:25PM
11:45AM
11:16AM
11:14AM
10:23AM
09:59AM
09:40AM
08:10AM
05:54AM
12:01AM
Feb-02-26 09:55PM
08:40PM
06:38PM
05:20PM
04:20PM
04:05PM
03:00PM
Jan-31-26 10:01PM
Jan-30-26 11:56AM
Jan-29-26 11:34PM
Jan-27-26 06:00PM
Jan-21-26 06:15PM
10:00AM
Jan-19-26 12:31PM
Jan-16-26 01:56PM
04:25AM
Jan-15-26 10:34AM
Jan-14-26 11:50AM
Jan-13-26 06:00PM
Jan-07-26 06:00PM
06:00AM
Jan-02-26 09:32AM
Dec-29-25 08:53AM
01:30AM
Dec-23-25 09:02AM
Dec-22-25 06:00PM
09:14AM
Dec-19-25 09:13AM
Dec-18-25 09:07AM
Dec-15-25 09:05AM
Dec-11-25 08:00AM
Nov-28-25 11:30AM
Nov-24-25 11:49AM
Nov-14-25 04:53PM
04:16PM
Nov-13-25 10:31PM
Nov-12-25 01:11PM
Nov-10-25 06:41AM
Nov-05-25 12:38AM
Nov-04-25 08:00AM
Nov-02-25 01:07PM
Oct-30-25 07:39PM
01:59PM
01:35AM
Oct-29-25 05:25PM
05:25PM
04:05PM
Oct-28-25 11:27AM
DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BERKSHIRE HATHAWAY INC10% OwnerMay 01 '26Sale149.841,220,376182,864,67928,880,209May 05 06:52 PM
Waters Kathleen AlyceChief Legal & Pub. Affairs OffFeb 06 '26Option Exercise108.938,079880,045105,833Feb 09 06:57 PM
ACKERMAN JOELCFO and TreasuerFeb 06 '26Option Exercise108.9344,0654,800,000185,705Feb 09 06:56 PM
BERKSHIRE HATHAWAY INC10% OwnerJan 29 '26Sale120.561,658,480199,939,88130,100,585Feb 02 05:30 PM
HEARTY JAMES OChief Compliance OfficerDec 04 '25Option Exercise108.935,875639,96431,913Dec 05 04:35 PM
BERKSHIRE HATHAWAY INC10% OwnerOct 27 '25Sale135.36401,51454,347,24931,759,065Oct 29 06:09 PM
BERKSHIRE HATHAWAY INC10% OwnerJul 31 '25Sale140.611,635,962230,024,76432,160,579Aug 04 09:00 PM
HEARTY JAMES OChief Compliance OfficerJul 23 '25Sale150.002,351352,65026,038Jul 24 08:34 PM
HEARTY JAMES OOfficerJul 23 '25Proposed Sale150.002,351352,650Jul 23 04:05 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 27 '25Sale139.45103,27414,401,48333,796,541May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 23 '25Sale137.8164,0668,828,93333,899,815May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 22 '25Sale138.9832,6604,538,98333,963,881May 27 09:34 PM
BERKSHIRE HATHAWAY INC10% OwnerMay 08 '25Sale147.111,145,938168,576,64733,996,541May 12 04:05 PM